Amunix Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 75
Rang # Quantité totale PI 17 876
Note d'activité PI 2,6/5.0    49
Rang # Activité PI 15 061
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

46 5
10 2
9 0
3
 
Dernier brevet 2025 - Extended recombinant polypeptide...
Premier brevet 2007 - Unstructured recombinant polymer...
Dernière marque 2023 - PRO-XTEN
Première marque 2014 - AMUNIX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Extended recombinant polypeptides and compositions comprising same. The present invention relate...
Invention Compositions targeting epidermal growth factor receptor and methods for making and using the same...
Invention Chimeric polypeptide assembly and methods of making and using the same. The present invention re...
Invention Compositions targeting prostate-specific membrane antigen and methods for making and using the sa...
Invention Compositions targeting prostate-specific membrane antigen (psma) and methods for making and using...
2023 Invention Her-2 targeted bispecific compositions and methods for making and using the same. Disclosed herei...
P/S Scientific and technological services, namely, chemical, biological, medical, pharmaceutical and ...
Invention Glucagon-like peptide-2 compositions and methods of making and using same. The present invention...
Invention Xten conjugate compositions and methods of making same. The present invention relates to extende...
2022 Invention Compositions and methods related to activatable therapeutic agents. Described herein are methods...
Invention Chimeric polypeptide assembly and methods of making and using the same. The present invention rel...
Invention Her-2 targeted bispecific compositions and methods for making and using the same. Disclosed here...
Invention Cytokine conjugates. The present invention relates to compositions comprising biologically activ...
P/S Biomedical compounds, namely, polypeptides for providing half-life extension; biomedical compound...
P/S Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scie...
Invention Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods...
2021 P/S Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; chemic...
P/S Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, polypeptides ...
P/S Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant a...
Invention Compositions and methods related to activatable therapeutic agents. Described herein are methods ...
Invention Cytokine conjugates. The present invention relates to compositions comprising biologically active...
Invention Coagulation factor ix compositions and methods of making and using same. The present invention r...
Invention Extended recombinant polypeptides and compositions comprising same. The present invention relates...
2020 Invention Barcoded xten polypeptides and compositions thereof, and methods for making and using the same. ...
Invention Barcoded xten polypeptides and compositions thereof, and methods for making and using the same. D...
Invention Egfr antigen binding fragments and compositions comprising same. The present disclosure related ...
Invention Cd3 antigen binding fragments and compositions comprising same. This disclosure relates to compo...
Invention Egfr antigen binding fragments and compositions comprising same. The present disclosure related t...
Invention Cd3 antigen binding fragments and compositions comprising same. This disclosure relates to compos...
2018 Invention Release segments and binding compositions comprising same. The present invention relates to activ...
Invention Xten conjugate compositions and methods of making same. The present invention relates to extended...
2017 Invention Treatment of adult growth hormone deficiency with human growth hormone analogues. The present di...
Invention Blood glucose lowering compound. The present invention relates to the field of medicine and the t...
2016 Invention Glucose-regulating polypeptides and methods of making and using same. The present invention relat...
2015 Invention Targeted xten conjugate compositions and methods of making same. The present disclosure provides...
Invention Growth hormone polypeptides and methods of making and using same. The present invention relates t...
2014 P/S Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations Pharmac...